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W O R K S H O P  R E P O R T
Technical Risk Assessment and Regulations
Co-chairs: Rebecca Goldburg, Biologist, Environmental Defense Fund 
William F. Greenlee, Pharmacology and Toxicology,
Purdue University
Products of agricultural biotechnology, such as field tests of genetically engineered crops or foods derived from genetically engineered crops, 
may pose risks to ecosystems or human health. However, the traditional risk 
assessment paradigm, developed to assess the carcinogenicity of chemicals, is 
not easily applied to products of agricultural biotechnology. Thus it is nec-
essary to develop new risk assessment approaches in order to assess the risks 
of many agricultural biotechnology products.
After making scientific assessments of the nature and magnitude of any 
risks, regulators and other decisionmakers must elect a course of action. This 
risk management process often involves weighing risks and benefits of a par-
ticular product. The process can be difficult for agricultural products (e.g., 
pesticides, whether genetically engineered or not), since many of the indi-
viduals who bear direct risks from these products may not be the primary 
beneficiaries of the products.
Workshop participants set out to identify issues and make recommenda-
tions concerning risk characterization and risk management in agricultural 
biotechnology. Participants were first split into three groups to identify im-
portant issues. From the large number of issues identified by all three groups, 
participants selected, by vote, three issues for further discussion. The selected 
issues were essentially consecutive steps in the risk characterization and man-
agement process:
Identify hazards of process/product 
Measure risks and establish scientific standards 
Balance risk and benefits
Workshop participants then divided back into three groups, one for each is-
sue, to develop recommendations. These three groups reported their recom-
mendations to the workshop as a whole, and all participants were given an op-
portunity to discuss the recommendations before they were made final. The 
third group noted that risk is a part of life, and many participants felt that 
consideration of biotechnology products should somehow involve benefits as 
well as risks. Balancing risks and benefits for agricultural biotechnology
products can be extremely difficult, however, especially when risks and ben-
efits are not, for the most part, borne by the same individuals or groups. No 
specific recommendations were agreed upon for balancing risks and benefits.
R E C O M M E N D A T I O N S
Identify Hazards of Process/Product
The National Academy of Sciences should study and develop strategies for hazard 
identification in agricultural biotechnology.
Regulators have extensive experience identifying the hazards of syn-
thetic chemicals, but this experience is not always directly applicable to 
agricultural biotechnology products.
More input is needed from the scientific community to develop hazard identi­
fication methodology for agricultural biotechnology products.
Legislative gaps should be filled (e.g.,fish, shellfish).
Regulatory agencies, in some instances, lack the authority to adequately 
address risks of agricultural biotechnology products. Fish and shellfish 
present a clear example of such a gap. No agency has a clear Congres-
sional mandate to regulate either the risks of releases of genetically engi-
neered fish and shellfish or to regulate the safety of fish and shellfish 
(genetically engineered or not) for human consumption.
Land-grant universities need to address issues such as sustainable agriculture, 
family farms, and pesticide use, for which biotechnology now serves as a 
lightening rod or even a surrogate focus.
Some agricultural biotechnology products are the focus of considerable 
criticism or opposition from individuals who believe that these products 
may exacerbate existing trends in agriculture. Many issues about the 
structure of agriculture, (e.g., the loss of family farms), merit public de-
bate. Unfortunately, few obvious forums are now available for public 
discussion of these issues. As a result, in some cases biotechnology 
products are serving as the primary vehicle for debate.
Government officials need to develop integrated approaches to regulation 
that incorporate knowledge of product and process.
As has been noted by many others, risk assessment of biotechnology 
products should be based on the characteristics of the products and not 
the fact that biotechnology was used to develop the product. Neverthe-
less, knowledge of the process used to develop a product can sometimes 
help form the questions asked in risk assessment or aid in decisions con-
cerning which products to assess (e.g., in assessing the safety of a drug, 
regulators often consider the process used in its manufacture because the 
process can affect the presence of impurities in the product). Regulation
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of biotechnology products should be based on science and the law, and 
not on ideological avoidance of all references to biotechnology.
Measure Risks and Establish Scientific Standards
Tools (appropriate test systems) should be developed to evaluate the potential 
hazards of three classes of organisms: animals, plants and microorganisms.
Scientific guidelines need to be developed to ensure that any ecological 
or human and animal health risks of agricultural biotechnology prod-
ucts are adequately addressed. The following are examples of areas that 
may merit the development of such “tools:”
Animals
-containment/ecological effect of releases 
-human safety of expressed products 
-unforeseen metabolic effects
Plants
-containment/ecological effect of releases: 
altered disease/insect susceptibility, 
weediness, and 
outcrossing.
-human safety of expressed products 
-unforeseen metabolic effects
Microorganisms
-containment/ecological effect of releases: 
colonization,
pathogenicity/toxicity to nontarget organisms, and 
frequency and impact of gene transfer to other microbial species, 
-unforeseen metabolic effects
Models should be developed to assess the toxicity and allergenicity/antigenic-
ity of expressed products as part of developing risk assessment guidelines.
It also should be noted that it is impracticable to measure any and all po-
tential unforeseen effects. One can only look for specified unforeseen ef-
fects of particular concern.
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WORKSHOP REPORT
Public Assessments of Benefits and Risks
Cochairs: Ted A. McKinney, Community Affairs & Contributions, DowElanco 
A. Ann Sorenson, Center for Agriculture and the Environment,
American Farmland Trust 
with Patrick A. Stewart, American Farmland Trust
The purpose of this workshop was to establish an understanding of the underlying reasons for public concerns about agricultural biotechnology. 
This was accomplished by dividing the 28 participants into three smaller 
groups to discuss issues and possible solutions followed by an open group 
discussion in order to reach consensus. Over the course of two days, the often 
spirited discussion revolved around public perceptions and ways in which to 
respond to the public’s need for credible information.
MAJOR THEMES
Discussions centered around two interrelated themes that came into sharp fo-
cus later on in the workshop. Both dealt with public perceptions of biotech-
nology. The first was a possible paradigm shift in the way the public thinks 
about the benefits and risks of biotechnology. The perception of the group 
was that there is no longer an unquestioning acceptance of the social para-
digm in which humans are seen as dominating the planet and its resources.
It is being replaced by an environmental paradigm, in which the public per-
ceives limits to growth. Biotechnology’s place in this new paradigm has not 
yet been determined, but its perceived role may affect its acceptance.
The second underlying theme that emerged from the workshop was that 
of the potential of biotechnology to bring about change. With the introduc-
tion and development of biotechnology, society has been given a powerful 
tool to change its environment in unforeseen ways. This leads to questions 
about how society should shape itself and who should make decisions as to 
the form and extent of change. This has understandably raised public con-
cerns. However, the workshop participants saw that decisions pertaining to 
biotechnology must be made because the technology cannot be suppressed, 
only channeled into desired uses. The participants further saw that if the 
public did not become involved in the decision-making process early on, the 
marketplace would make decisions in its absence.
These two themes are seemingly in conflict. On the one hand, many 
people are fearful of new technologies and express an increasing desire for
nonintervention in the ecology of the planet. On the other hand, biotechnol-
ogy offers the possibility of more controlled and targeted interventions into 
the environment, minimizing negative side-effects. Ironically, even as science 
has developed a technology that can change the environment, the public’s 
perception and acceptance of biotechnology has turned away from the prom-
ise of benefits, and focused on risks associated with technological change. 
Technical analysis of benefits and risks is no longer sufficient to assure accep-
tance of biotechnology. Increasingly, an appraisal of the public’s perception 
of those risks and benefits by stakeholders must be considered as well.
STAKEHOLDERS
The participants felt it was important to define who the stakeholders in pub-
lic assessment of risks and benefits associated with agricultural biotechnol-
ogy are. The stakeholders fall into five broad groupings:
Government: Local, state and federal level policymakers in the legisla-
tive, executive/administrative and judicial branches. 
Universities/Research Organizations: Groups providing the scientific 
knowledge and information on which policy decisions are often 
based.
Special Interest Groups/Organizations: Groups with an interest in pre-
serving or changing the social and economic status quo. These in-
clude environmental groups, farm groups, industry/trade organiza-
tions, health groups, unions, religious groups and others. 
Corporations/Organizations Funding Research: Organizations creating 
products and technologies to serve their constituents/consumers. 
Consumers/The Public: Individuals directly affected by the production 
and consumption of biotechnology.
ISSUES
Workshop participants identified three major issue areas in public percep-
tion of agricultural biotechnology: personal issues, societal issues and pro-
cess issues. Intervention to influence public policy can take place at any of 
these levels.
Personal Issues
Personal issues deal with how an individual views the impact of biotechnol-
ogy on themselves. Personal issues identified by workshop participants in-
cluded: food safety/health, economic impact, environmental/animal health, 
and the spiritual/moral-ethical dimensions of genetic engineering.
Food Safety/Health: Questions about the safety of food manipulated 
through genetic engineering and its impact on human health are of particu-
lar concern for the agricultural biotechnology industry.
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Economic Impact: Individual concerns over the economic impact of ag-
ricultural biotechnology center around possible positive and negative impacts 
on jobs and the introduction of new products into the market.
Environmental/Animal Health: Individuals are becoming increasingly 
aware of negative impacts to both the environment and animals. The percep-
tion of agricultural biotechnology’s role in ameliorating or aggravating current 
conditions will influence the acceptance and use of agricultural biotechnology.
Spiritual/Moral-Ethical Dimensions: Some individuals seem to have a 
“gut reaction” to biotechnology, not necessarily connected with religious be-
liefs, that no amount of scientific knowledge or data will change.
Societal Issues
Societal issues deal with ties between society and its leaders, and the strength 
of those ties. Again, in no particular order, the participants identified the fol-
lowing issues:
Trust: Public involvement in policymaking has increased in the past two 
decades. Citizens are increasingly suspicious that policymakers, who they see 
as manipulated by private interests, may be trying to manipulate them. This 
leaves them wondering who to trust with decision-making and who to turn to 
for credible information. Debate over the scientific accuracy of information 
also has contributed to a basic distrust of authority.
Motives: The public also has developed a distrust of some individuals 
and groups on the basis of their motives. They perceive an imbalance between 
those who bear the risk and those who benefit in society. The brunt of this 
distrust has been directed at industry because of its necessary focus on profit-
making.
Socioeconomic Concerns: There was concern over the possible impacts 
of biotechnology on the socioeconomic structure of groups and communities. 
The possibility of concentration of ownership of food production through 
control of biotechnology is disconcerting to some. The potential impact of 
agricultural biotechnology on small and medium-size farms, and its possible 
contribution to the loss of a traditional way of life, is of special concern.
Process Issues
The third tier of concern was that of process issues, or how policies are made 
and who makes them.
Public Policy: Questions over public policy on biotechnology focused on 
who determines policy, who should determine the policy, and how policy 
should be implemented. There was an expressed need to find a process of 
technology control with which the public is comfortable and involved.
Public Understanding of Agricultural Biotechnology: The issue of 
public knowledge was seen as going beyond that of agricultural biotech-
nology to science and technology as a whole. Participants felt that lack of
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public knowledge was understated by most people and that some people 
simply are not concerned or likely to ever be concerned about the impacts of 
biotechnology on their lives. In spite of this, there was a desire to distribute 
accurate information ranging from the technical aspects, the socioeconomic 
impacts and the moral/ethical concerns of biotechnology.
Public Attitude About Biotechnology: There was a two-pronged ques-
tion about the public’s attitude concerning agricultural biotechnology and 
how to assess it. The public currently receives information from competing 
channels: special interest groups, media, government, industry and university 
sources. Because these messages often conflict, public attitudes about bio-
technology are shaped by what appears to be the most trustworthy source. It 
is at this point that information moves from being a scientific issue to being a 
political issue.
Process and Value of Measuring Public Response to Risk: The value of 
measuring public perception of risk was questioned for two reasons. First, 
gaps between the public’s statements of what it would do and what it actually 
does always exist. Second, even if such information were known, changing 
public attitudes is difficult.
What Does the Public Think vs. What is Known: There was a belief that 
the majority of public decisions are made on the basis of emotion and limited 
information. This is of great concern to researchers and industry who must 
deal with a public that cares little about science and must attempt to bridge 
the gap between science and the public’s understanding of it.
SUMMARY STATEMENT
After much discussion, workshop participants agreed on the following sum-
mary statement on public assessment of risks and benefits of bio technology:
We recognize that technical assessment is not the only factor in public 
acceptance of technology. We recognize the need for better understanding 
of personal and societal values. We also recognize the need to under-
stand the factors influencing public attitudes about biotechnology and 
biotechnology-derived products on the part of stakeholders.
RECOMMENDATIONS
On the basis of the preliminary discussions, the combined group developed 
recommendations for dealing with personal, societal and process issues. 
These objectives address the concerns outlined in the group’s summary 
statement:
Develop and implement methods of identifying and monitoring public under-
standing of and awareness about issues and potential changes being brought 
about through biotechnology.
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Greater support is needed for social science research through multiple 
methods such as surveys, informal information gathering, expanded dia-
logues between stakeholders, public forums and content analysis.
Place additional emphasis within education and the educational process on 
defining, assessing, and understanding risk and decision-making under uncer-
tainty.
Expand the capacity and commitment of the scientific community to more ef-
fectively communicate with the public.
Expand to an ongoing dialogue about the implications of the knowledge 
being generated.
Place additional emphasis on science education in kindergarten through 
twelfth grade.
Expand public dialogue and discussion about the forces of change being gener-
ated by biotechnological developments beyond traditional channels (the Fed-
eral Register, Public Comment, university extension services, etc.) in order to 
reach the public at the grassroots level.
Broaden involvement of stakeholders in identification of priority needs to be 
addressed by biotechnology.
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WORKSHOP REPORT
Public Values: Benefits and Harms
Cochairs: Rosetta Newsome, Scientific Affairs and Information,
Institute for Food Technologists 
Lilly-Marlene Russow, Philosophy, Purdue University
The workshop began with clarification of the topic of the workshop, and howit might be separated from the other topics. It was noted that the 
concepts of benefit and harm—particularly the latter—were considerably 
broader than the more specific idea of risk. “Risk” tends to invite a focus 
on health and safety issues, while benefits and harms extend beyond these 
specific concerns. Nonetheless, it was clear that the topic is very broad, that 
nearly every question about biotechnology is a question about public values, 
and hence that any attempt to predetermine the focus of the workshop would 
restrict the discussion too much. Two themes were repeatedly emphasized:
1. public values grow out of attempts to acknowledge and balance the values 
of diverse individuals; and 2. the whole issue of public values must consider 
the process by which values are shaped, expressed and recognized.
IDENTIFYING ISSUES
The participants were asked first to identify, and then to prioritize, topics of 
greatest concern. The results were as follows. Issues are listed in the order 
they were assigned as the result of vote, with comments voiced by participants 
and examples of topics within specific issues included under each general 
heading1. Topics are reproduced exactly as formulated by the workshop, since 
in many cases there was substantial debate about the wording. The results of 
the voting upon which the ranking was based are included. The first issue, 
identified below, ranked considerably higher than the others2.
1 The summaries under the heading “Elaboration/Analysis of Major Issues” reflect 
only the initial discussion. The workshop discussed the top-ranked issues in more 
depth on the second day; the discussions are summarized under the heading 
“Other Issues.”
2 Each participant was asked to list all seven topics in order of importance. Each list 
was then weighed, with the issue listed first receiving a “1”, the second a “2”, and 
so on to the last, which received a “7.” Since there were sixteen participants who 
voted, there was a possible range of 16-112 points, with the lower numbers rep-
resenting the issues judged more important.
Who should have the right or power to make decisions that have broad 
social implications? (29 points). Participants decided to consider the ques-
tion of who ought to have a voice, rather than simply to ask how decisions 
are currently made. Participants pointed out that public institutions are 
poorly funded and need to be empowered, and that a sharp, reductionistic 
divide between science and technology and other sources of value (e.g., reli-
gion or spirituality) exists. More generally, this topic encompasses the ques-
tions of who sets research agendas, who shapes and controls the regulatory 
process, how the food-production system is determined and controlled, and 
who decides what products are available.
What criteria are used to assign value to new biotechnology? (53 points). 
The discussion began with a look at how the public views biotechnology and 
other “new” technologies in contrast with familiar products and processes. 
Some view new scientific discoveries as “progress,” and “new” as equivalent 
to “better” or “improved.” However, at least since Hiroshima, others express 
increasing numbers of questions, and perhaps skepticism, about the wisdom 
and value of some so-called “advances.”
How safe is safe enough? (59 points). This discussion began with the 
observation that people today have different expectations about safety than 
they did earlier; they are more likely to raise questions about the safety of ev-
erything from food to playgrounds than they were fifty years ago. Although 
safety is only one factor in public value, it is important enough, and complex 
enough, to warrant careful consideration. Participants noted that there were 
conflicting ideas about what is included in judgments about safety. Percep-
tions of safety were tied to control in that something one can choose to avoid 
(e.g., bungee jumping) is less likely to raise serious safety concerns than 
things that are more difficult to avoid (e.g., drinking water). It was also 
pointed out that there are discrepancies between what people say they want 
and what they are willing to pay for, but that economic and class value systems 
were important factors to keep in mind. The importance of avoiding an elitist 
structure was emphasized: safety should not be a luxury limited to those who 
can afford to pay for it. On the other hand, concern about safety rarely over-
rides basic needs—one participant mentioned that people starving in Sudan, 
or even getting canned food from a soup kitchen, are less likely to worry 
about insect damage or contamination than affluent Americans.
What communication is needed among all citizens affected by biotech-
nology? (65 points). Preliminary versions of this topic were phrased in terms 
of information, but people soon changed to a discussion of communication 
in order to emphasize the need for true dialogue and the importance of 
avoiding an arrogant “us vs. them” attitude. Specific questions noted under 
this general heading were: 1. what sort of information consumers need and 
want; 2. the concept of “informed consent” and what that standard requires;
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and 3. what sort of information regulators and legislators need in order to 
reach decisions.
How does biotechnology affect distribution of assets, incomes and 
power? (73 points). In general, public values will vary according to who wins 
and who loses through biotechnological advances. If large corporations are 
perceived as profiting while small family farms are perceived as harmed (as 
the bST/bGH controversy is sometimes portrayed), biotechnology is more 
likely to be viewed as harm. A more specific subheading under this issue had 
to do with the impact of biotechnology on the structure of the food produc-
tion and distribution system.
What is the environmental impact of biotechnology? (85 points). There 
was little initial discussion of this issue, but subsequent comments indicated 
that it included, among other things, affect on the type and quantity of 
pesticide used, water quality and biodiversity. On the issue of biodiver-
sity, one participant pointed out that more thought must be given to the 
choice of plant species used, e.g., to develop substances such as plastic 
substitutes. Choosing alfalfa rather than corn as a ‘host’ for example, the 
participant said, would be beneficial in that it would help stem the ten-
dency towards monocultures and their attendant problems.
How should concerns for animals be taken into account? (93 points). 
There was considerable debate about the wording of this point. Some people 
wanted to describe the issue in terms of a contrast between concern for ani-
mal welfare and animal rights (“Should animal welfare be expanded to in-
clude animal rights?”). Others felt that terms like “animal rights” were 
prejudicial and unclear, and that a broader and more neutral description of 
the issue would be preferable. By majority vote, the form given above was 
chosen by the group.
E laborat ion /Analysis  of  Major  Issues
The workshop was then asked to break into two subgroups to explore the two 
issues identified as the most important topics. Each group was given one 
topic, and asked to identify: 1. barriers which hindered the group from 
addressing the issue effectively and appropriately, and; 2. recommenda-
tions about how to deal with the issue and the associated barriers. The 
barriers and recommendations developed by each subgroup were then 
presented to the entire workshop for discussion.
Who Should Have the  Right or Power to Make Decisions That Have  
Broad Social Implications?
The subgroup which discussed this highest-ranking issue began by iden-
tifying the various sorts of “players” in the process of evaluating biotech-
nology. The following were identified: 1. regulators (including legislators
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and regulatory agencies such as USDA, FDA, etc.); 2. developers (industry, 
scientists, granting agencies, academia); and 3. consumers (including both 
consumers in the literal sense of people who buy a product and also people 
seeking other benefits, such as environmental groups). The news media were 
also cited as players which can wield significant influence.
Next, the group identified the following barriers:
—Exactly what people want to know is not always known.
—Not everyone wants to get involved; some people want someone else to 
make the decisions. Consumers typically are overwhelmed; scientists 
typically want to be left alone to focus on their own work.
—Current procedures for gathering views and disseminating information 
are too formal to be widely effective (e.g., most people do not read the 
Federal Register).
—A common base of shared knowledge cannot be presupposed.
—In determining value, the scientific processes which are learned, the in-
vestigative tools which are developed and the advances in basic science, 
not just the concrete products of biotechnology need to be considered.
—The complexities of diverse cultures and value systems need to be un-
derstood and respected. This will affect, among other things, choices 
about whether, when and how, to compete with other countries in the 
international marketplace.
—Although the current political forum in which policy is shaped is sup-
posed to be democratic, questions are raised concerning how demo-
cratic it is in practice.
Recommendations
Finally, the group offered two recommendations:
Increase the opportunity for “friendly” participation in the formal process. A 
system is needed which encourages and fosters broad participation, and which 
really listens and responds to input from all stakeholders.
Congressional hearings, by contrast, are often unfriendly, and people 
who testify often leave with the feeling that their input made no difference.
Real discussion (as opposed to mere dissemination of information) needs to be 
promoted among broad and diverse audiences.
NABC meetings represent a valuable first step, but do not represent the 
diversity of positions and values that must ultimately be included.
What Criteria are Used to Assign Value to New Biotechnology?
The second subgroup identified barriers and made recommendations re-
garding this second major issue. Barriers fell into two major categories. 
Several examples are identified in each category.
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The first category of barriers or complexities in defining value or public 
good concerned the heterogeneity of people affected by biotechnology and public 
values. Religious, ethnic, economic, age and educational differences were all 
thought to effect how people judge the benefits and harms of biotechnology. 
Specific biotechnological developments will rarely be perceived similarly by 
all segments of the population. Moreover, people differ with respect to their 
willingness and/or ability to accept risks.
The second category of barriers related to information, and the difficulty 
of getting information into a public forum early enough. Full and free ex-
change of information is often hindered by concerns for intellectual property 
rights, the proprietary interests of an industry and competitiveness between 
industries, the desire of scientists to keep findings to themselves until their 
work has been published, and regulatory restrictions on discussion of prod-
ucts under regulatory review. It was suggested that there is a possible “win-
dow of opportunity” for earlier exchange of information after a patent has 
been granted, yet prior to marketing. This suggestion was countered by the 
observation that the restrictions of the patent process limit this potential 
“window.” Participants recognized that within the current system, a signifi-
cant investment, both public and private, is made before public value is fully 
established.
Recommendations
The group then offered several specific recommendations to help overcome 
the problems inherent in dealing with the heterogenicity of the public.
While the general theme reflected an encouragement of broad public in-
volvement and consideration, these items were considered more as examples 
than as a complete list. The following suggestions were identified:
Be sensitive to religious concerns and provide information in food labeling ac-
cordingly.
Develop information which is clear and understandable, so as to be accessible 
to people with a variety of educational backgrounds.
Assess the social/economic impacts of specific biotechnology applications at 
the earliest stage possible.
Specifically, applications should not adversely impact individuals in the 
low income sector, e.g., applications that would raise significantly the 
cost of foods should be avoided.
Establish a societal “minimum acceptable risk level,” recognizing that some 
products or processes might be too risky to be acceptable at all; and identify 
risk levels of acceptable applications to enable individuals to make personal 
decisions about risk acceptability.
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To deal with information barriers, the group suggested:
Land-grant universities and extension offices be singled out as particularly 
appropriate forums for discussion and dissemination of information.
However, effective functioning in these roles requires increased funding, 
more attention to and respect for extension activities as part of the origi-
nal mission of land-grant institutions, and more autonomy from industry 
support.
More attention be given to the “window of opportunity” (see above).
Information should be exchanged and made available as widely as pos-
sible during this period, and consideration should be given to modifying 
the processes and regulations to allow for better exchange of informa-
tion as soon as possible. Thus, open forums (designed to encourage per-
sonal communication and dialogue, not promotion) during the early 
stages of development before beginning marketing, need to be fostered. 
This would require, among other things, clarification of restrictions on 
discussion of patent applications under review and products under 
regulatory review.
Finally, participants offered a variety of additional criteria likely to arise in 
various applications of biotechnology. This list is not to be interpreted as 
recommended standards or criteria to be formally incorporated into the ap-
proval process, but rather, items which warrant consideration as early as pos-
sible in the developmental process. The difficulty of accurately projecting 
impact of various applications was recognized, though. The first point men-
tioned in this regard was the need to pay attention to both long-term and 
short-term impact, people evaluate a product on the basis of what its impact 
maybe in twenty years as well as what it maybe now.
Other criteria mentioned were: impact on the food supply—nutritional 
value, food quantity, quality, variety and cost, and impact on the structure of 
agriculture. With regard to agricultural structure, concerns were: Will the 
application accelerate vertical integration and the role of farmers in the 
decision-making process and will it impact the sustainability of the process?
Is government support required? Impact of the new development on current 
products and on food production were also offered.
Environmental concerns generated another set of possible criteria. Wa-
ter quality, sustainabililty and biodiversity were a few of the concerns that 
were highlighted. International effects also were mentioned, including com-
petitiveness and impact on Third World or developing nations. Finally, eco-
nomic and social considerations were brought up again, with particular em-
phasis on concern for equitable distribution of financial gains.
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O T H E R  I S S U E S
The detailed discussion of the two most important issues did not leave much 
time to pursue the other topics that had been identified during the first ses-
sion. Nonetheless, some of the lower-ranking topics (e.g., the environment) 
had been taken up in the course of discussing one or both of the first two is-
sues, and some discussion of the third and fourth issues (safety and commu-
nication) was possible. The variety of participant comments on the third 
and fourth issues are detailed below.
How Safe is Safe Enough?
Several barriers were noted. The first was short-term versus long-term 
safety considerations. A related point emphasized generational consider-
ations, and the fact that people are often willing to take risks for themselves, 
but not for their children. (Alar was cited as an example of this point). Sec-
ond, the public is increasingly unwilling to trust science and industry, and to 
view assurances from these sectors with suspicion. Next, the tension that of-
ten arises between public safety and individual freedom and choice was men-
tioned. Laws requiring motorcycle helmets, and New Jersey’s short-lived at-
tempt to prevent restaurants from serving soft-boiled or sunny-side up eggs 
were cited as examples. Finally, the apparent failure of our educational sys-
tem to provide people with an adequate understanding of scientific methods 
and the limits of science, for example, was cited.
Recommendations
These problems gave rise several recommendations:
The need for better education at all levels, beginning with kindergarten.
The need to avoid absolutes when talking about safety.
Nothing is simply or absolutely safe, and this requires open communica-
tion about levels of safety.
It is necessary to take a much broader perspective when considering safety. 
One should attempt to evaluate the whole process, source as well as out-
come. In considering Salmonella contamination for example, all stages 
of the poultry and egg production process are to be evaluated, not just 
egg preparation and consumption practices.
What Communication Is Needed Among All Citizens Affected by  Biotechnology?
This last issue addressed the need to improve communication. The main 
point conveyed here was the need to communicate on an effective, personal 
level, which requires, among other things, listening to public concerns as
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well as providing information in an appropriate way. Educational levels and 
vocabulary were two factors that should be kept in mind. Realism is always 
necessary; practitioners must listen to real situations expressed by the pub-
lic. It also was recognized that many individuals exhibit a narrow vision or 
focus on their own specific agenda, and that communication may be ham-
pered by people’s unwillingness to get involved, or doubt about whether they 
should really care about these issues.
Recommendations
To address these problems, the group recommended:
Better support for land-grant institutions and extension offices.
Better education programs at the K-12 levels.
More strenuous efforts to support scientific societies (e.g., Institute of Food 
Technologists) with information for broad dissemination.
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WORKSHOP REPORT
   Public Communication About Risk
Co-chairs: Karen Bolluyt, Agricultural Information Services,
Iowa State University 
David Judson, Gannett News Service
MISSION
To provide society the information it needs to evaluate the potential risks and 
benefits of agricultural biotechnology.
BACKGROUND
Certain basic principles can guide all involved in public communication 
about risk as it relates to biotechnology.
Opinions about risk vary from one perceived risk to another. Peter Sand-
man, professor of environmental communication at Rutgers University, has 
described “outrage factors” that drive personal assessments of risk. Commu-
nication about any perceived risk should include an analysis of the risk in 
light of factors that influence personal perceptions of risk. According to 
Sandman, these include: 1. individual control in assuming risk (voluntary vs. 
involuntary exposure); 2. fairness or the extent to which a risk is distributed 
equally; 3. morality or the extent to which technology or behavior not only 
poses a risk but is perceived to be evil; 4. dread, e.g., the belief that the poten-
tial damage may be catastrophic or may cause a fatal, lingering illness; 5. fa-
miliarity, as illustrated in the difference between fear that peanut butter may 
contain carcinogens or the fear that irradiation may change foods in undesir-
able ways; and 6. trust as earned or lost in all areas of organizational behavior.
Some elements of modern technology help cause increased perceptions 
of risk. These include: 1. the improved ability to detect toxic substances (one 
part per quintillion); 2. new technology that is not understood except by 
people with exceptional skills or highly specialized education; 3. knowledge of 
catastrophes or instances in which technology believed to be beneficial proved 
to be harmful (e.g., thalidomide); 4. experts disagreeing during litigation, 
hearings or other widely publicized public discussions; 5. growing production 
and distribution systems that increase the potential for technologies and 
products to affect millions of people each day, thus increasing the chances for 
catastrophe; and 6. growth in knowledge and the accompanying growth in 
awareness of gaps in knowledge (How valid are methods of risk assessment?).
Categorizing some perceptions of risk as “irrational fears” interferes with 
risk communication and is a counterproductive substitution for thoughtful
exploration of issues/answers. “Many risk experts insist that ‘the data’ alone, 
not the ‘irrational’ public, should determine policy. When a risk manager 
continues to ignore [outrage] factors—and continues to be surprised by the 
public’s response of outrage—it is worth asking just whose behavior is irra-
tional.” (Sandman, 1987)
The long-term view for risk communication is that society and/or con-
sumers determine the success or failure of new technology and new products. 
This long-term outlook should drive communications plans and activities.
In the United States a majority of people express some belief that bio-
technology in agriculture can benefit them and express some support for the 
development of biotechnology. The public strongly expresses a need/desire 
for information about biotechnology and for the opportunity to be involved 
in decisions about the use of biotechnology in the development and use of 
products.
Communication is not the easy task of message distribution once the 
difficult decisions about financing, research, development, marketing, etc. 
are made. It is a crucial, complex, continuous, circular interchange that 
should be a central part of all planning and budgeting. In general, communi-
cation plans and efforts have been inadequate.
R E C O M M E N D A T I O N S
The workshop participants prepared recommendations on three topics: 
communication content, credible communication, and circular communica-
tion. Some recommendations were made for more than one topic, but each 
is reported only once here.
Communication Content
Communication should contain more than facts. Opinions and values should 
enter the communication mix at every juncture, and that is taken into account 
later in this report. The following recommendations regarding factual infor-
mation were made:
Communicate in specifics as much as possible.
Focus on specific products or technologies, risks or benefits.
Focus on what a product/technology will mean to specific audiences.
Use simple language (old, short words).
Prepare to be brief and concise about key ideas and information, and be pre-
pared to provide detail (probably written).
For all sources of information, identify the source’s qualifications and af-
filiations.
Base information on sound science.
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Credible Communication
Beginning with the assumption that credibility must be earned and con-
ferred, that it can not be claimed or bought, the following recommendations 
were made:
Provide full disclosure of information about benefits, risks, and the assump-
tions on which the information is based.
Be clear and forthright in describing biases or financial interests that an audi-
ence should understand to evaluate information and opinions from various 
sources.
Provide product information and 1. provide, or 2. make it easy to obtain pro-
cess information.
Do not simply state conclusions; provide background information about 
how conclusions were reached and distinguish between opinion and fact.
Use language and concepts that the audience understands.
Clarity is credible. People are more likely to be suspicious of what they 
do not understand.
Choose spokespeople carefully, considering each audience and using the 
audience’s criteria for trustworthiness.
Build bridges with key groups by identifying people who can serve as liaisons. 
All members of most groups will not become experts in biotechnology, 
so they identify a trusted group member or liaison who is knowledgeable 
and they rely on him or her for guidance.
Circular Communication
If one accepts the proposition that the consumer will be one of the primary 
determining factors in the process of acceptance, then there are two critical 
communication questions to be addressed: 1. How do we provide the infor-
mation consumers need? and 2. How do we develop and maintain effective 
feedback from consumers? This process is complex, but it has a circular na-
ture that provides points of reference for plans and actions. These points of 
reference are: 1. provide information for the forum of pubic debate; 2. listen 
to the feedback in the ensuing dialogue; and 3. go back to point one. The fol-
lowing recommendations for establishing circular communication are made:
Listen more than you talk.
All participants should make special efforts to listen attentively, with the 
goal of understanding the facts and beliefs behind various points of 
view. A corollary to this is that multiple sides of an issue should be pre-
sented during meetings/discussions.
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Adopt the wheel model for risk com-
munication. (right)
The hub is society/the con-
sumer. The spokes are con-
duits for information flowing 
to and from the public, and the 
rim is the arena of interaction 
containing multiple sources of 
information and opinion. Any 
poorly functioning part of the 
wheel will have a negative im-
pact on the whole.
Identify the stakeholders at the rim 
of the wheel, and key individuals and 
groups among the general public at the hub.
Deciding whether an individual or group belongs at the rim or in the hub 
will be a useful part of communication planning.
Identify the communication channels.
Define the role, the costs and the importance of each channel, and de-
velop communication plans accordingly. Among the channels that might 
be used to exchange information are the following: K-12 education, 
land-grant institutions—particularly their extension services, interper-
sonal communication, mass media, targeted media, coalitions, focus 
groups and surveys, consumer behavior, organizational boards, and for-
mal or informal opinion leaders.
The following were selected recommendations for channels of communication:
Increase funding for such programs as “Ag in the Classroom.”
Science teachers’ associations should be invited to cooperate in planning 
educational programs.
Provide scholarships for teachers and students that could bring them to uni-
versity and industry labs as interns or workshop participants.
Take advantage of all opportunities to build coalitions. Bringing together 
groups that disagree often works.
Areas of disagreement are based partly in misunderstandings and lack of 
information. Common ground and common goals often can be identi-
fied. Such coalitions can become credible communications channels be-
cause they do not represent a single point of view.
Share new and existing information from focus groups and surveys as widely as 
possible.
This is one efficient way to identify problems and issues early and to 
build general understanding of biotechnology and of public opinion and 
behavior.
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Use the land-grant model for coordinating communication.
Cooperative Extension might be empowered to build and coordinate co-
operative agricultural biotechnology communication programs.
Identify and use opportunities for interpersonal communication.
Several decades ago, research on the adoption of innovations pointed to 
the importance of interpersonal communications for decision-making. 
Recent research on risk communication indicates that human behavior 
has not changed in this regard. This inefficient channel for communica-
tion may be the only effective channel/best channel in many instances. 
Organizations should make interpersonal communication (i.e., listening 
and talking) a strategic part of communication plans.
Use mass media and targeted media to reach audiences and to elicit responses 
from them.
Media relations strategies have changed considerably with the growth of 
special interest publications. There never has been any such creature as 
“the general public,” but media targeted at specific groups have increased 
in importance while many “mass media,” (e.g., daily newspapers) have 
decreased. The role of mass media and more targeted media as sources 
of facts and as mechanisms for calling attention to issues also has re-
mained relatively stable since the time of the adoption-diffusion studies 
of the 1940s.
Use the body of communications research on the role of these communications 
channels to plan risk communications.
Advise organizations and institutions to incorporate diverse points of view into 
their leadership.
This should begin with The National Agricultural Biotechnology 
Council.
Recognize the importance of informal and formal leaders.
For many issues, formal and informal leaders are sought out for their 
opinions. Sometimes they are in decision-making positions, but not al-
ways. They are, however, channels for information. Special efforts 
should be made to understand how they obtain information and to keep 
them informed.
Communication about biotechnology is a complex process that requires equal 
attention to facts about the science and understanding of human behavior. It 
requires planning, resources and respect for the consumer. It can be frus-
trating. Poorly executed, it can create ill will and a great drain on resources 
directed at damage control. It should receive careful as the attention from 
the beginning of any efforts in biotechnology.
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